Capital Fund Management (CFM)
RMD icon

Capital Fund Management (CFM)’s ResMed RMD Stock Holding History

Capital Fund Management (CFM)’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,800
Closed -$3.86M – 2221
2024
Q3 		$3.86M Sell
15,800
-6,400
-29% -$1.43M 0.01% 1143
2024
Q2 		$4.25M Sell
22,200
-40,600
-65% -$8.24M 0.01% 1029
2024
Q1 		$12.4M Sell
62,800
-50,800
-45% -$9.31M 0.04% 635
2023
Q4 		$19.5M Buy
113,600
+70,300
+162% +$10.8M 0.05% 457
2023
Q3 		$6.4M Buy
+43,300
New +$7.83M 0.02% 811
2020
Q1 		– Sell
-11,100
Closed -$1.72M – 1950
2019
Q4 		$1.72M Sell
11,100
-10,300
-48% -$1.48M 0.01% 900
2019
Q3 		$2.89M Buy
+21,400
New +$2.8M 0.03% 664

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Capital Fund Management (CFM)'s RMD Position: Q3 2025 in Review

Capital Fund Management (CFM) sold out of ResMed (RMD) in Q3 2025, closing a stake of 33,559 shares — an estimated $9.17M sold.

Capital Fund Management (CFM) first reported a position in RMD in Q2 2013 and held it in 23 quarters. The position peaked at $14.7M in Q2 2023. 949 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Capital Fund Management (CFM) reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 33,559 ResMed shares in Q3 2025, an estimated $9.17M.
  • Capital Fund Management (CFM) first reported a position in ResMed in Q2 2013 and held it in 23 quarters.
  • Capital Fund Management (CFM)'s ResMed position peaked at $14.7M in Q2 2023.
  • 949 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2025, filed 13 Nov 2025.